Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Understanding Immunologic Complications of Measles

Ruth Jessen Hickman, MD  |  Issue: August 2025  |  August 6, 2025

Although overall MMR vaccination rates in Texas are about 94%, in Gaines County, the location of the Mennonite community, overall rates are 82%. Most public schools nationwide require some sort of mandatory vaccine schedule, including MMR, with some state exceptions for medical conditions or personal beliefs. Vaccination rates for home-schooled or private school students may be much lower.12,13

Kevin Winthrop, MD, MPH, a pro­fessor of public health and infectious diseases at Oregon Health and Science University, Portland, notes the true numbers of cases are probably much higher than the officially confirmed cases would indicate because many patients may not come to medical attention.

Dr. Winthrop

“If measles gets into a pool of people where there’s little vaccination,” says Dr. Winthrop, “it’ll spread like wildfire.”

In the webinar, Dr. Salmon expressed concern that if we were to reach a point of widespread community transmission it would be very hard to eliminate the disease again. “We could see substantial morbidity and mortality,” he said. “So I’m quite worried.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Management Considerations

With respect to prevention and management of measles infections, many of the recommendations for the general population also apply to people with rheumatologic diseases. One important caveat is that certain rheumatology patients should not receive live vaccines such as the MMR, out of concern for vaccine-associated illness.

Assess Immunity & Vaccination Status

Dr. Winthrop notes that in light of media coverage of measles, many rheuma­tology patients are concerned about their immunocompromised status. They’re asking whether their vaccinations are up to date and wondering if they may need revaccination.

“If someone hasn’t been vaccinated before, now is a good opportunity to do that,” says Dr. Winthrop. However, he notes, in most circumstances, practitioners can reassure previously vaccinated patients that neither re-vaccination nor retesting immunity via IgG titers is necessary. “If a patient [were at] high risk for exposure, like a healthcare worker in the heart of the outbreak in Texas, I would certainly check titers and make sure they’re adequate, and if not, give them a booster,” he says.

Dr. Calabrese does not routinely recom­mend IgG titers to check for immunity status in patients with documented, appropriate MMR vaccination because the test may underestimate the level of immunity actually present. “The vast majority of our patients are protected against measles, either [they] had measles as a child or [were] appropriately vaccinated. It just comes down to figuring out their vaccine and natural immunity history,” she says. “But I would caution patients not to travel to areas of active outbreaks.”

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesGuidance Tagged with:BiologicsImmunityimmunocompromisedimmunosuppressioninfectious diseaselive vaccineMeaslesMMRoutbreakspublic healthvaccinationvaccine hesitancy

Related Articles
    phichet chaiyabin / shutterstock.com

    Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

    August 16, 2019

    Despite the presence of a highly effective vaccine, measles (rubeola) is still an important problem worldwide, one that has reemerged in some areas of the world where it had previously been almost eradicated. Rheumatology patients may have questions about whether they are sufficiently protected. Here we discuss key considerations for rheumatologists in light of recent…

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

    Space & Other Races

    October 19, 2020

    On April 5, 1950, a small group of scientists met in Silver Spring, Md., to talk about geophysics. I know this is not the most riveting way to start, but if you stick with me, I promise the story will get much more interesting. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEThis group of scientists met to discuss…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences